使用水友制药辅助剂来调节从弹性质体中释放金属离子
Xin Shen1, Xinyu Zhao1, Clare F McCoy1
1School of Pharmacy, Queen's University Belfast, Belfast, UK.
Drug delivery
|August 21, 2025
概括
这项研究通过使用制药辅助剂,增强了阴环中金属离子释放的效果. 辅助剂显著增加了铜和离子的释放,为非荷尔蒙避孕和抗菌疗法提供了潜力.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 药物输送系统 药物输送系统
背景情况:
- 弹性体 (聚甲基) 是生物相容,不可生物降解的聚合物,广泛用于药物输送装置.
- 目前的基产品提供疏水性药物;由于溶解度低,控制金属离子如铜和的释放仍然具有挑战性.
- 开发用于非激素避孕和抗微生物治疗的多用途阴道环需要增强的金属离子释放.
研究的目的:
- 研究增强弹性体器件中的铜 (Cu2+) 和 (Zn2+) 离子体内释放的方法.
- 评估金属纳米粉末或盐与常见药品辅助剂共同配制对离子释放动态的影响.
主要方法:
- 将铜/纳米粉末,硫酸铜或酸纳入加固弹性体中.
- 与制药辅助剂共同配制:凝,聚烯利,糖糖和基甲基纤维素.
- 在体外释放研究量化Cu2+和Zn2+离子扩散从矩阵.
主要成果:
- 铜/纳米粉和盐成功地被纳入了弹性体.
- 与纳米粉末加载的弹性体加载双价金属盐的离子释放量比加载纳米粉末的弹性体大约增加了100倍.
- 加入凝,聚烯,糖和基甲基纤维素增强了Cu2+/Zn2+离子释放量,达到30倍.
- 增强的离子释放与增加的吸水和弹性体装置的胀相关,取决于辅助剂负载.
结论:
- 制药助剂可以显著增强弹性体器件的金属离子释放.
- 增强释放的机制涉及水的吸收和装置的胀,受辅助剂的类型和度的影响.
- 这种方法有望开发基于的先进阴道环,用于局部输送金属离子,用于治疗和避孕应用.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...